Rani Therapeutics Holdings, Inc.
Ticker: 1856725
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q1 FY25 | Q2 FY21 | Q2 FY21 | Q1 FY21 | Q3 FY20 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.71+0.0% | 1.71+0.0% | 1.71+905.9% | 0.17-91.3% | 1.96+0.0% | 1.96+157.9% | 0.76+590.9% | 0.11 |
| Total Income | 1.71+0.0% | 1.71+0.0% | 1.71+905.9% | 0.17-91.3% | 1.96+0.0% | 1.96+157.9% | 0.76+590.9% | 0.11 |
| EXPENSES | ||||||||
| Expenditure | 10.93+3.7% | 10.54+4.9% | 10.05-17.6% | 12.19+68.8% | 7.22+0.0% | 7.22+21.3% | 5.95+102.4% | 2.94 |
| Tax | — | — | — | — | 0.00 | 0.00-100.0% | 0.04+300.0% | 0.01 |
| PROFIT | ||||||||
| PBT | — | — | — | — | -5.48+0.0% | -5.48+1.4% | -5.56-93.1% | -2.88 |
| Net Profit | -7.73-4.6% | -7.39-5.1% | -7.03+3.2% | -7.26-32.2% | -5.49+0.0% | -5.49+2.0% | -5.60-94.4% | -2.88 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.04+0.0% | -0.04+0.0% | -0.04+81.8% | -0.22 | — | — | — | — |
Corporate Events
Board MeetingRANI
20261Aug
Board Meeting
Director Appointment — Michelle Gilson appointed to the Boar…
SEC Filing ↗ Board MeetingRANI
202628May
Board Meeting
Annual Meeting of Stockholders — Election of directors and r…
SEC Filing ↗ Board MeetingRANI
202615May
Board Meeting
CFO transition; Alireza Javadi appointed CTO; Jesper Høiland…
SEC Filing ↗